Overview

Effects of TT301 on Cytokine Levels Post Endotoxin Challenge

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of TT301 on cytokine levels in healthy male volunteers participating in an endotoxin challenge.
Phase:
Phase 1
Details
Lead Sponsor:
OPKO Health, Inc.
Transition Therapeutics